drug

teplizumab-mzwv

1 story · latest Nov 9, 2026

Follow teplizumab-mzwv. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Nov 2022 · BLA761183
Brand: Tzield
Code: SAR446681
Trials: 4 registered trials in coverage

Relationships

Developed by Sanofi

Also known as

teplizumab

Timeline

Sanofi's Japan teplizumab trial for Stage 2 Type 1 Diabetes is active, not recruiting

Nov 9Trial updateSanofi teplizumab-mzwv

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.